Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer.

MLA

Kudela, M., et al. “Prognostic Importance of Selected Molecular Immunohistochemical Markers and DNA Ploidy in Endometrial Cancer.” European Journal of Gynaecological Oncology, vol. 33, no. 2, Mar. 2012, pp. 159–63. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=75258178&authtype=sso&custid=ns315887.

APA

Kudela, M., Pilka, R., Lubusky, M., Hejtmanek, P., Dzubak, P., & Brychtova, S. (2012). Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer. European Journal of Gynaecological Oncology, 33(2), 159–163.

Chicago

Kudela, M., R. Pilka, M. Lubusky, P. Hejtmanek, P. Dzubak, and S. Brychtova. 2012. “Prognostic Importance of Selected Molecular Immunohistochemical Markers and DNA Ploidy in Endometrial Cancer.” European Journal of Gynaecological Oncology 33 (2): 159–63. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=75258178&authtype=sso&custid=ns315887.